Table of Contents
Overview
New York, NY – July 30, 2025 : The global Image-Guided Radiation Therapy (IGRT) market is set to grow from US$ 2.1 billion in 2024 to US$ 4.3 billion by 2034. This reflects a strong CAGR of 7.4% during the forecast period. The rising incidence of cancer worldwide is a key driver. Patients and healthcare providers increasingly prefer IGRT due to its ability to target tumors with high accuracy. It reduces damage to surrounding healthy tissues, making it a vital tool in modern cancer treatment protocols.
Technological innovations are also pushing the market forward. Advanced systems now use real-time imaging through CT, MRI, and cone-beam CT. Integration of artificial intelligence (AI) and adaptive radiotherapy enhances treatment precision. These advancements improve patient outcomes and reduce side effects. As technology becomes more sophisticated, hospitals and cancer centers are rapidly adopting IGRT systems. This trend is especially evident in developed markets with strong healthcare infrastructure and a focus on precision medicine.
Growing awareness of early cancer detection further supports market growth. Investments in radiation oncology are increasing, particularly in emerging economies. Countries in Asia-Pacific and Latin America are expanding access to advanced therapies. Governments and private institutions are building new cancer treatment centers. This expansion is creating more opportunities for IGRT system providers. Rising healthcare spending and support for cancer care infrastructure are key growth enablers in these regions.
Despite the positive outlook, several challenges remain. IGRT systems are expensive and require skilled professionals to operate. This limits adoption in low- and middle-income countries. Reimbursement issues and uneven access to healthcare technologies also restrict growth. Many hospitals in developing regions lack funds or trained staff. These barriers create a gap between demand and availability. Addressing affordability and training gaps is essential for broader market penetration.
Key trends shaping the IGRT market include AI-driven personalization and the shift to outpatient care. More healthcare providers are partnering with tech companies to enhance service delivery. Compact and cost-effective systems are being developed to meet the needs of smaller clinics. As innovation continues, the global push for precision cancer care will drive steady growth. Overall, the market presents strong potential, especially with rising global efforts to improve oncology outcomes through targeted therapy.
Key Takeaways
- In 2024, the global image-guided radiation therapy (IGRT) market was valued at USD 2.1 billion and is set for strong future growth.
- By 2034, the IGRT market is projected to reach USD 4.3 billion, expanding steadily at a compound annual growth rate (CAGR) of 7.4%.
- Among imaging techniques, the computed tomography (CT) segment led the global market in 2024, capturing approximately 31.2% of total revenue.
- Breast cancer emerged as the dominant application area in 2024, accounting for a 31.4% share of global IGRT market revenues.
- Hospitals remained the top end-user in the IGRT market, holding a 44.3% revenue share due to widespread adoption of advanced radiation technologies.
- North America retained its leadership in the global IGRT market in 2024, contributing over 36.3% of total revenue, driven by strong healthcare infrastructure.
Regional Analysis
North America holds the largest share in the global image-guided radiation therapy (IGRT) market. This is due to its advanced healthcare infrastructure and high cancer prevalence. The region benefits from early adoption of innovative technologies and strong oncology centers. It also has a solid base of medical device manufacturers and ongoing R&D investments. Favorable reimbursement policies and government support drive IGRT adoption. Technologies like AI integration and adaptive radiotherapy boost market growth. These factors collectively maintain North America’s dominant position in the global IGRT market.
Another key factor for North America’s leadership is the availability of skilled professionals. Growing awareness about precise cancer treatment is also boosting demand. Healthcare providers in the region focus on reducing side effects and improving outcomes. This aligns well with the purpose of IGRT. The integration of smarter, more accurate systems is gaining momentum. As a result, IGRT systems are becoming standard in many oncology centers. North America is expected to sustain its leadership as innovation and patient-centric care continue to evolve.
Asia-Pacific holds the second-largest share in the global IGRT market. The region’s growth is driven by a rising cancer burden and improving healthcare infrastructure. Countries like China, India, and Japan are witnessing high cancer incidence. This is increasing the demand for accurate and advanced therapies. Governments are investing heavily in oncology services. Growing awareness, early detection, and technological adoption are pushing IGRT usage. Local manufacturing, strategic partnerships, and affordability are improving access. With expanding radiation oncology centers, Asia-Pacific is emerging as a key market for IGRT solutions.
Segmentation Analysis
The global image-guided radiation therapy (IGRT) market is segmented by product type into CT scanners, ultrasound systems, MRI, endoscopes, X-ray fluoroscopy, PET, and SPECT. Among these, the CT segment led the market with a 31.2% share in 2024. This dominance is driven by CT’s high precision and ability to improve treatment accuracy. CT imaging helps localize tumors and reduce damage to healthy tissue. Innovations such as 4D-CT and cone-beam CT are enhancing real-time tumor tracking, which is crucial for improving radiotherapy outcomes and treatment planning.
CT’s integration with modern radiation therapy systems makes it a preferred option across healthcare facilities. Its rapid image acquisition and enhanced resolution aid clinicians in better tumor visualization. Companies like Philips and FUJIFILM are investing in next-generation CT systems, driving technological progress. For instance, Philips launched its AI-powered CT 5300 in January 2025, while FUJIFILM received FDA clearance for its 128-slice FCT iStream in June 2024. These innovations highlight the ongoing shift towards precise, image-based cancer care worldwide.
The application landscape is led by the breast cancer segment, holding a 31.4% market share in 2024. Rising breast cancer incidence is a key factor in this growth. IGRT offers precise tumor targeting, reducing harm to healthy tissues. Technological advancements such as CT, MRI, and cone-beam CT integration support better imaging and treatment. Increased awareness, regular screenings, and favorable reimbursement policies are fueling demand. Hospitals, with a 44.3% share, dominate end-use due to their advanced facilities, skilled teams, and ability to manage complex cancer cases effectively.
Key Segments Analysis
By Product Type
- Computed Tomography (CT) Scanners
- Ultrasound Systems
- Magnetic Resonance Imaging (MRI)
- Endoscope
- X-ray Fluoroscopy
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
By Application
- Breast Cancer
- Lung Cancer
- Brain Tumor
- Prostate Cancer
- Gastrointestinal Cancer
- Gynecological Cancer
- Other Applications
By End-use
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Research & Academic Institutes
Key Players Analysis
The image-guided radiation therapy (IGRT) market features intense competition among major global players. Key companies include Varian Medical Systems (a Siemens Healthineers company), Elekta AB, Accuray Incorporated, ViewRay, and Brainlab. These firms focus on advancing precision imaging, adaptive radiotherapy, and AI integration. They invest heavily in R&D to improve treatment accuracy and patient outcomes. Strategic partnerships, mergers, and collaborations with hospitals are common. Additionally, regional manufacturers in Asia-Pacific offer cost-effective solutions, adding to the competitive pressure in the global IGRT market.
As cancer rates rise globally, the demand for efficient and precise treatment solutions increases. This trend is pushing companies to innovate continuously. Siemens Healthineers AG, a division of Siemens AG, is a leading force in imaging and digital health. It operates in over 70 countries and is known for its innovations in MRI, CT, and radiotherapy. Medtronic plc, based in Ireland, also contributes to the market. With a presence in 150 countries, it offers advanced therapies for cardiac, neurological, and spinal conditions.
Top Key Players in the Image Guided Radiation Therapy Market
- Philips
- Medtronic
- Siemens Healthineers
- Analogic Corporation
- GE Healthcare
- Varian Medical Systems Inc.
- Brainlab AG
- Olympus Corporation
- Stryker
- GE HealthCare
Emerging Trends
1. Shift Toward Adaptive Radiotherapy
Cancer centers are now using IGRT systems that adjust radiation in real time. These systems respond to changes in tumor shape or size during treatment. This means doctors can adapt the dose every day. It helps improve treatment accuracy and reduces the chance of damaging healthy tissues. Adaptive radiotherapy is especially helpful for tumors that move or shrink quickly. This trend shows a shift toward more personalized care. As technology improves, more hospitals are expected to adopt this method. The main goal is to boost treatment outcomes while lowering side effects for patients.
2. Integration of Artificial Intelligence (AI)
AI is becoming a key part of modern IGRT systems. It helps analyze images faster and improves treatment planning. AI can quickly detect small changes in tumor position or size that human eyes might miss. This allows doctors to adjust therapy more accurately. It also supports faster clinical decisions, which saves time for both patients and healthcare teams. AI tools are being used in real-time monitoring and in predicting treatment responses. As AI keeps advancing, its role in IGRT will likely grow. This trend points toward smarter and more efficient cancer care.
3. More Use of MRI and PET in IGRT
While CT scans are still common in IGRT, MRI and PET imaging are gaining popularity. These technologies provide clearer, more detailed views of soft tissues and tumors. MRI does not use radiation, which makes it safer for repeated imaging. PET scans can show how active a tumor is by tracking metabolic changes. Using these advanced tools helps doctors target tumors more precisely. This leads to better treatment accuracy and fewer side effects. The move toward MRI and PET is helping improve outcomes, especially for complex or hard-to-reach cancers.
4. Increased Focus on Patient Comfort and Safety
New IGRT machines are being built with patient comfort in mind. These systems work faster and produce better-quality images. They also reduce the amount of radiation patients receive. This lowers the risk of long-term side effects. Shorter treatment times make the overall experience easier, especially for elderly or pediatric patients. Some machines even allow more flexible patient positioning. All these improvements help reduce stress during therapy. As patient-centered care becomes a bigger priority, safety and comfort features will continue to evolve across IGRT systems.
5. Remote Planning and Cloud-Based Platforms
IGRT systems are now supported by cloud-based platforms. These allow doctors to create and adjust treatment plans remotely. It is especially helpful in rural areas or countries with fewer specialists. Teams can collaborate across locations in real time. This means patients get access to expert care, no matter where they live. Cloud systems also improve data storage, backup, and sharing. They make updates and reviews faster and more secure. With more clinics adopting remote tools, cloud-based planning is shaping the future of cancer treatment workflows.
6. Rising Popularity of Proton Therapy with IGRT
Proton therapy is a very precise form of radiation treatment. When combined with IGRT, it becomes even more accurate. This method helps protect nearby healthy tissues, especially in sensitive areas like the brain, spine, or eye. IGRT guides the proton beams to the exact tumor location. As a result, patients often experience fewer side effects. Proton therapy is also safer for children whose bodies are still developing. More cancer centers are investing in this powerful combination. It offers high effectiveness with minimal damage, making it ideal for complex cancer cases.
7. Growing Use in Non-Traditional Cancer Types
IGRT was once used mainly for prostate, head, and neck cancers. Today, its use is expanding to treat many other cancer types. These include breast, lung, liver, pancreatic, and even pediatric cancers. This wider application shows that IGRT is effective across various tumor locations. Doctors now use it for cancers that are hard to reach or tend to move, like lung tumors. As research grows, the list of treatable cancers will likely expand further. The increased flexibility and precision of IGRT make it a valuable tool in modern cancer therapy.
Use Cases
1. Prostate Cancer Treatment
Image-guided radiation therapy (IGRT) plays a key role in treating prostate cancer. The prostate gland can move slightly each day due to changes in the bladder or bowel. This movement makes it hard to target the tumor with radiation. IGRT uses daily imaging to track the exact position of the prostate before each treatment. This allows doctors to adjust the radiation beams precisely. As a result, the radiation targets the tumor and avoids healthy organs like the bladder and rectum. This precision reduces side effects and improves outcomes for prostate cancer patients.
2. Lung Cancer Management
Treating lung cancer with radiation is tricky because the lungs move when we breathe. This constant motion can cause the tumor to shift position during treatment. IGRT helps solve this problem. It uses real-time imaging to monitor the tumor’s location as the patient breathes. This allows radiation to be delivered accurately, even when the tumor moves. By using IGRT, doctors can focus the radiation on the tumor while protecting nearby healthy tissue. This leads to safer and more effective treatment for people with lung cancer.
3. Brain and Spine Tumors
Brain and spine tumors require highly precise treatment. These areas are very sensitive, and even a small mistake can harm critical nerves or brain tissue. IGRT ensures that radiation is delivered exactly where it is needed. It provides clear, high-quality images before and during each session. This allows doctors to guide the radiation with great accuracy. As a result, healthy brain or spinal tissues are protected, and side effects are minimized. IGRT is especially useful for treating tumors near the spinal cord or deep inside the brain.
4. Breast Cancer Radiation Therapy
In breast cancer care, IGRT helps protect the heart and lungs during radiation. This is very important, especially when treating cancer in the left breast. The heart lies close to the left breast, so small positioning errors can lead to radiation exposure. IGRT provides imaging that allows doctors to carefully target the tumor area. This means radiation is focused only on the breast tissue that needs treatment. By reducing radiation to healthy areas, IGRT lowers the risk of long-term complications and improves treatment accuracy.
5. Pediatric Cancer Care
Children need special care during cancer treatment because their bodies are still developing. Radiation can have long-term effects on growing organs. IGRT is helpful in pediatric cancer cases because it allows for lower and more accurate doses of radiation. Doctors use detailed imaging before each treatment to adjust the radiation beams. This means the tumor gets treated while surrounding healthy tissues are protected. With IGRT, the risk of side effects is reduced, and children have a better chance of healthy growth after therapy.
6. Post-Surgical Tumor Site Treatment
After surgery to remove a tumor, radiation is sometimes needed to kill any leftover cancer cells. IGRT helps doctors target the exact area where the tumor was. This is important because the body changes after surgery, and the treatment area might shift slightly. With daily imaging, IGRT ensures the radiation dose is delivered precisely. This improves the chances of killing remaining cancer cells without harming healthy tissues nearby. It also helps reduce the chance of cancer returning in the same area.
7. Re-Treatment of Recurrent Tumors
Sometimes cancer comes back in the same place where it was treated before. Giving radiation again in that area is challenging. The tissues have already been exposed to radiation, so doctors must be extra careful. IGRT makes re-treatment safer and more accurate. It uses advanced imaging to pinpoint the tumor’s location and adjust the radiation path. This helps protect healthy tissues that are already sensitive. IGRT allows patients to get another round of radiation when needed—without causing extra harm to their bodies.
Conclusion
In conclusion, the global image-guided radiation therapy market is on a strong growth path, driven by rising cancer cases, better technology, and a shift toward precise treatment methods. IGRT offers major benefits, such as accurate tumor targeting and fewer side effects, which make it a key tool in modern cancer care. As awareness grows and healthcare systems improve, especially in emerging regions, the demand for IGRT will keep increasing. Challenges like high costs and the need for trained staff remain, but ongoing innovation and support from governments and private sectors are helping to overcome these issues. With advancements in AI, imaging, and patient-centered care, the IGRT market holds strong potential for long-term success.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
